NTLA Chart
- 52-Week Range: $39.94 - $176.78
- Market Capitalization: $3.33B
- Short Percentage: 0%
- Target Price: $136.65
- Shares Outstanding: 75.85M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
NTLA released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Intellia Therapeutics' (NTLA) CEO John Leonard on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 24th
- Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based TherapiesGlobeNewsWire | February 23rd
- Intellia Therapeutics Announces Two Upcoming Investor Events in February 2022GlobeNewsWire | February 17th
Company Info
Website: https://www.intelliatx.com
Address: 40 Erie Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 485
Address: 40 Erie Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 485
$NTLA gonna take my L with this one
$NTLA Growth/Value
$NTLA the best advice has been no stop losses. Would have cost a fortune!!!
$NTLA looks like a loading
$NTLA tomorrow im gunna have a fucking good day regardless if its red or green. Red is buy green is hodl.
$NTLA I'm friggin bored. Just give us our money already
$NTLA beauty. Bag secured
$NTLA Good morning traders
$NTLA I love this stonk!
$NTLA oh my!